Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Gastrointestinal bleeding upper)
10,803 results
  • Massive Spontaneous Hemothorax as a Complication of Apixaban Treatment. [Journal Article]
  • CRCase Rep Pulmonol 2018; 2018:8735036
  • Abu Hishmeh M, Srivastava P, … Murthy S
  • CONCLUSIONS: Spontaneous hemothorax is a rare complication of anticoagulant therapy and might not exhibit the usual radiological signs of traumatic hemothorax. Health care providers should have high index of suspicion for spontaneous hemothorax when evaluating new pleural effusion in patients receiving DOACs therapy. Drainage by small bore pigtail catheter might be as effective as larger chest tubes.
  • Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices. [Journal Article]
  • SMSouth Med J 2018; 111(11):666-673
  • Shah R, Qayed E
  • CONCLUSIONS: After LVAD implantation, there is a fivefold increased risk of readmission with GI bleeding within 60 days. Gastroduodenal and small intestinal arteriovenous malformations are the most common culprit lesions. These findings suggest that small bowel enteroscopy should be considered as the initial test of choice in patients with suspected upper gastroduodenal bleeding. Readmissions with bleeding in patients with LVADs increase morbidity and cost of care but not mortality. Older patients and those with a history of bleeding during LVAD implantation are at higher risk of bleeding readmission and may benefit from close monitoring and cautious anticoagulation to prevent rebleeding.
  • Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. [Review]
  • CDCochrane Database Syst Rev 2018 Oct 29; 10:CD011510
  • Zacharias AP, Jeyaraj R, … Morgan MY
  • CONCLUSIONS: We found no clear beneficial or harmful effects of carvedilol versus traditional, non-selective beta-blockers on mortality, upper gastrointestinal bleeding, serious or non-serious adverse events despite the fact that carvedilol was more effective at reducing the hepatic venous pressure gradient. However, the evidence was of low or very low quality, and hence the findings are uncertain. Additional evidence is required from adequately powered, long-term, double-blind, randomised clinical trials, which evaluate both clinical and haemodynamic outcomes.
New Search Next